Finasteride and the Prevention of Prostate Cancer

The document discussed the potential preventive effects of finasteride on prostate cancer, a common malignancy with increasing incidence with age. Finasteride was known to inhibit the conversion of testosterone to dihydrotestosterone, an active androgen in the prostate, which led to reduced prostate volume, improved urine flow, and fewer symptoms in cases of benign prostatic hyperplasia. However, no treatment was available to prevent the onset of prostate cancer entirely.